{"id":1926,"date":"2024-08-09T05:35:57","date_gmt":"2024-08-09T05:35:57","guid":{"rendered":"http:\/\/www.rnm.in\/blog\/?p=1926"},"modified":"2025-01-30T10:55:39","modified_gmt":"2025-01-30T10:55:39","slug":"mankind-pharma-to-buy-bharat-serums-as-advent-international-exits","status":"publish","type":"post","link":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/","title":{"rendered":"Mankind Pharma to Buy Bharat Serums as Advent International Exits"},"content":{"rendered":"

Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV)
\nfrom private equity firm Advent International for an enterprise value of $1.63 billion
\n(around INR 13,630 crore). The move marks a \u201csignificant leap\u201d for Mankind
\nPharma, positioning it as a market leader in the Indian Women\u2019s health and fertility
\ndrug market. The acquisition will also provide Mankind access to other high-entry
\nbarrier products in critical care with established complex R and D tech platforms. Moelis
\nand Company acted as the executive financial advisors and AZB and Partners acted as
\nlegal counsel to Mankind Pharma. Advent and BSV were advised by Jefferies LLC
\nand J.P. Morgan as financial advisors and Khaitan and Co as legal counsel.
\n(Source: VC Circle, 26th July 2024)<\/em><\/p>\n

Private Equity<\/h2>\n

KKR to Acquire Kerala Hospital in Year\u2019s Third India Healthcare Deal<\/h3>\n

Private Equity firm KKR struck a deal to acquire a majority stake in Kerala based
\nBaby Memorial Hospital (BMH), two years after making a blockbuster exit from North
\nIndia chain Max Healthcare. The PE firm routed the transaction through its Asian
\nFund IV to support Baby Memorial Hospital to build a Pan-India network of hospitals,
\nboth organic and inorganic routes. KKR will pick up a stake of around 70% for as
\nmuch as $240 million (around INR 2,000 crore). This is a third healthcare related by
\nKKR in India this year.
\n(Source: VC Circle, 1 st July 2024)<\/em><\/p>\n

Brookfield Adds to India Renewables Portfolio with Acquisition of Leap Green<\/h3>\n

Canadian Investment firm Brookfield Asset Management Inc has stepped up its play
\nin India\u2019s renewable energy sector with the acquisition of a majority stake in Tamil
\nNadu based Leap Green Energy. Brookfield will make a $200 million (around INR
\n1,670 crore) upfront equity investment in Leap Green, founded by the family of
\nIndia\u2019s first Formula One driver Narain Karthikeyan. The green energy firm seeks to
\nincrease capacity to above 3 GW in capacity in the coming four to five years.
\n(Source: VC Circle, 11 th July 2024)<\/em><\/p>\n

NSE gets another private equity backer as valuation hits new high<\/h3>\n

The National Stock Exchange (NSE), India&#39;s largest stock exchange, has added
\nanother private equity investor, US-based Global Alternative Investment
\nManagement (GAIM), through a secondary transaction. GAIM, which focuses on
\nunique private equity and venture capital opportunities, acquired shares at INR 3,850
\nor INR 4,150 each, valuing NSE at $23-25 billion (around INR 1,92,000 \u2013 2,08,800
\ncrore). This is a significant premium over ChrysCapital\u2019s recent valuation rollover at
\n$16.8 billion (around 1,40,300 crore). ChrysCapital had previously transferred its
\n3.93% stake in NSE for around $660 million (around INR 5,511 crore).
\n(Source: VC Circle, 12 th July 2024)<\/em><\/p>\n

ValueQuest Bets $36 Mn on Solar Cell Maker Jupiter<\/h3>\n

Boutique equity investor ValueQuest has invested $36 million (around INR 300
\ncrore) in Kolkata based photovoltaic solar cell maker Jupiter International Ltd,<\/p>\n

founded in 2009 by Alok Garodia. The investment will allow Jupiter to expand its
\ncurrent cell capacity and to begin module manufacturing operations. At present, the
\ncompany has a cell manufacturing capacity of 800MW. Jupiter International is
\nplanning to set up a 1.8GW solar cell manufacturing capacity and a 1.2GW solar
\nmodule manufacturing facility.
\n(Source: VC Circle, 16 th July 2024)<\/em><\/p>\n

Biogas Plant Maker Gruner Renewable Raises $60 Mn<\/h3>\n

Gruner Renewable Energy, a Noida based company set up in 2023 providing biogas
\nsolutions, raised $60 million (around INR 500 crore) in equity finding. Gruner will
\nutilize the capital to set up new compressed biogas (CBS) plants across the country,
\nand to expand its operations presence in the market. This will include scaling up
\nCNG retail outlets, and exploring new business verticals such as sustainable aviation
\nfuel (SAF) and green hydrogen.
\n(Source: VC Circle, 29 th July 2024)<\/em><\/p>\n

Venture Capital<\/h2>\n

Abu Dhabi Wealth Fund ADIA Bets $120 Mn on Purplle<\/h3>\n

ADIA invested $120 million (around INR 1,000 crore) to increase its stake in the
\nunicorn via a primary infusion of capital and through a secondary purchase of shares
\nfrom some other shareholders, Purplle. Verlinvest, Goldman Sachs and some angel
\ninvestors were among the sellers. The round valued Purplle at $1.25 (around INR
\n10,430 crore). Purplle will use the primary capital to improve access to customers
\nand deliver products to them quicker; in addition to expanding its private label
\nbusiness. Apart from ADIA, Purpple has raised funds from Peak XV Partners,
\nKedaara Capital, PremjiInvest, Verlinvest, and Blume Ventures, among others.
\n(Source: VC Circle, 1 st July 2024)<\/em><\/p>\n

Agritech Firm Arya.Ag Snags $29 Mn from Blue Earth Capital, Quona Capital<\/h3>\n

Agritech platform Arya.ag, operated by Arya Collateral Warehousing Services Pvt.
\nLtd, has raised $29 million (around INR 242 crore) in a Pre-Series D funding round.
\nSwitzerland based investment firm Blue Earth Capital led the round. The round also
\nsaw participation from existing investors Asia Impact and Quona Capital. Setuka
\nPartners served as the strategic advisor for the equity round. The grain-commerce
\nstartup will use the funds to develop its technological stack and add more users to
\nthe platform.
\n(Source: VC Circle, 10 th July 2024)<\/em><\/p>\n

ResponsAbility, MS Dhoni Leas Pre-Series B Funding of EV Ride Hailing Co BluSmart<\/h3>\n

Home-grown electric vehicle (EV) ride hailing company BluSmart completed pre-
\nseries B round raising $24 million (around INR 201 crore) from multiple investors
\nincluding Swiss impact investor responsAbility, cricketer MS Dhoni\u2019s family office,
\nReNew Power\u2019s chief executive Sumant Sinha, amongst other existing investors.
\nBluSmart\u2019s latest fundraising, post a $42 million (around INR 350 crore) bridge
\nround, will be used to support expansion plans.
\n(Source: VC Circle, 15 th July 2024)<\/em><\/p>\n

Dharana Capital Bets $50 Mn on Urban Company<\/h3>\n

India focused Investment firm Dharana Capital, which has backed domestic
\ncompanies such as NoBroker, Zomato, Zooper, Lentra and Itilite, has invested $50
\nmillion (around INR 400 crore) in Urban Company via secondary transaction.<\/p>\n

Dharana Capital bought shares from Urban Company\u2019s employees and other
\nshareholders. Vamsi Duvvuri, founder and managing director of Dharana Capital, will
\njoin Urban Company\u2019s board as a non-executive director.
\n(Source: VC Circle, 17 th July 2024)<\/em><\/p>\n

Simple Energy Raises $20 Mn; Funds to Help Scale Production as Deliveries Start<\/h3>\n

Non Electric Vehicle and clean energy startup Simple Energy raised $20 million
\n(around INR 167 crore) in its latest funding round that saw participation from the
\ncompany\u2019s current investors, including family offices of Haran, Dr. A Velumani,
\nVesavi, and Desai, promoter group of Apar Industries, among others. The company
\nplans to scale up the production of electric two-wheelers. The fund will also support
\nthe company\u2019s entry into new markets, expand its presence across India, and
\nfacilitate new product development.
\n(Source: VC Circle, 29 th July 2024)<\/em><\/p>\n

Mergers and Acquisitions<\/h2>\n

CASHe Acquires Centcart to Foray into Insurance Broking<\/h3>\n

Aeries Financial Technologies Pvt. Ltd., which operates fintech startup CASHe, has
\nforayed into insurance broking services with the acquisition of Hyderabad based
\nCentcart Insurance Broking Services Pvt. Ltd. CASHe claims to have disbursed
\nINR10,200 crore worth of digital loans over 3 million users across India over the last
\nseven years. With a direct insurance broker license, it can now sell life, health, and
\nvehicle insurance products from all insurance companies in India. This shall further
\nallow CASHe to expand its presence across key sectors of the fintech industry,
\nincluding lending, wealth management, and insurance domains.
\n(Source: VC Circle, 10 th July 2024)<\/em><\/p>\n

Indusland Adani-IHC Joint Venture Sirius Digitech to Acquire Cloud Firm Coredge.Io<\/h3>\n

Sirius Digitech Ltd, a joint venture between billionaire Gautam Adani-led Adani
\nGroup and Abu Dhabi-based International Holding Company (IHC) unit Sirius
\nInternational Holding, will acquire cloud platform company Coredge.io to expand its
\nofferings for data centre operations through cloud and artificial intelligence (AI)
\nsolutions. As per agreement, Sirius Digitech will buy a 77.5% stake in Coredge\u2019s
\nparent Parserlabs India Pvt Ltd. Parserlabs owns 100% of Coredge.io. The cost of
\nacquisition will be INR 20,000 per equity share.
\n(Source: VC Circle, 17 th July 2024)<\/em><\/p>\n

Nazara Technology Buys out Promoters in Paper Boat, Raises Stake to 100%<\/h3>\n

Listed gaming firm Nazara Technology bought an additional 48.42% stake in Paper
\nBoat Apps Pvt Ltd, making the company that develops and publishes popular
\nlearning app kiddopia its wholly-owned subsidiary. Nazara Technology, which has
\nbought 50.91% stake in Paper Boat Apps in 2019, is buying the rest of the stake in
\ntranches from promoters Anupan and Anshu Dhanuka for around $35 million (around
\nINR 300 crore). Nazara Technology aims to drive growth and expansion of the
\nKiddopia franchise through IP licensing and integration, global market expansion,
\nand additional revenue streams including merchandising, video, and advertising
\nrevenues.<\/p>\n

(Source: VC Circle, 19 th July 2024)<\/em><\/p>\n

Insurtech Platform Acko Acquires Healthcare Manager OneCare<\/h3>\n

General Atlantic backed digital insurance provider Acko, acquired digital chronic care
\nmanagement company OneCare, as the company looks to create a comprehensive
\nhealthcare ecosystem. The acquisition is a strategic move to re-emphasize Acko\u2019s
\nbroader vision of being a comprehensive healthcare provider to its customers going
\nbeyond the insurance services. The transaction will see OneCare founders Rakesh
\nShivran and Sagar Bhat joining he leadership team of Acko.
\n(Source: VC Circle, 24 th July 2024)<\/em><\/p>\n

Ultra Tech Board Approves $472 MN Deal to Take Control of India Cements<\/h3>\n

UltraTech Cement, India\u2019s number one cement maker approved a $472 million
\n(around INR 3,954 crore) deal to gain control of India Cements, which will bolster its
\nposition in the country\u2019s southern states. UltraTech, part of India\u2019s Aditya Birla group,
\nwill buy a 32.72% stake in India Cements at INR 390 per share from its promoters
\nand their associates, adding to the 23% stake it bought in June.
\n(Source: VC Circle, 29 th July 2024)<\/em><\/p>\n

Related Services\u00a0 – Mergers and Acquisitions Consulting Services<\/a><\/p>\n

 <\/p>\n

You might also be interested in : Consultancy Firm in India<\/a> | Audit Firms in India<\/a> | GST Consulting<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion (around INR 13,630 crore). The move marks a \u201csignificant leap\u201d for Mankind Pharma, positioning it as a market leader in the Indian Women\u2019s health and fertility drug market. The acquisition will also provide Mankind […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[20],"tags":[],"class_list":["post-1926","post","type-post","status-publish","format-standard","hentry","category-corporate-finance"],"yoast_head":"\nMankind Pharma to Buy Bharat Serums as Advent International Exits<\/title>\n<meta name=\"description\" content=\"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mankind Pharma to Buy Bharat Serums as Advent International Exits\" \/>\n<meta property=\"og:description\" content=\"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\" \/>\n<meta property=\"og:site_name\" content=\"RNM India Blogs\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-09T05:35:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-30T10:55:39+00:00\" \/>\n<meta name=\"author\" content=\"Rnm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rnm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\"},\"author\":{\"name\":\"Rnm\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/c803658b38f2490f6a75863d05644438\"},\"headline\":\"Mankind Pharma to Buy Bharat Serums as Advent International Exits\",\"datePublished\":\"2024-08-09T05:35:57+00:00\",\"dateModified\":\"2025-01-30T10:55:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\"},\"wordCount\":1551,\"publisher\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/#organization\"},\"articleSection\":[\"Corporate Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\",\"url\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\",\"name\":\"Mankind Pharma to Buy Bharat Serums as Advent International Exits\",\"isPartOf\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/#website\"},\"datePublished\":\"2024-08-09T05:35:57+00:00\",\"dateModified\":\"2025-01-30T10:55:39+00:00\",\"description\":\"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rnm.in\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mankind Pharma to Buy Bharat Serums as Advent International Exits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#website\",\"url\":\"https:\/\/www.rnm.in\/blog\/\",\"name\":\"RNM India Blogs\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rnm.in\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#organization\",\"name\":\"RNM India Blogs\",\"url\":\"https:\/\/www.rnm.in\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rnm.in\/blog\/wp-content\/uploads\/2024\/08\/cropped-logo.png\",\"contentUrl\":\"https:\/\/www.rnm.in\/blog\/wp-content\/uploads\/2024\/08\/cropped-logo.png\",\"width\":137,\"height\":72,\"caption\":\"RNM India Blogs\"},\"image\":{\"@id\":\"https:\/\/www.rnm.in\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/c803658b38f2490f6a75863d05644438\",\"name\":\"Rnm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/719d6dbaa9fb6a42b8e1c14dec8f0172?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/719d6dbaa9fb6a42b8e1c14dec8f0172?s=96&d=mm&r=g\",\"caption\":\"Rnm\"},\"url\":\"https:\/\/www.rnm.in\/blog\/author\/rnm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mankind Pharma to Buy Bharat Serums as Advent International Exits","description":"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/","og_locale":"en_US","og_type":"article","og_title":"Mankind Pharma to Buy Bharat Serums as Advent International Exits","og_description":"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.","og_url":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/","og_site_name":"RNM India Blogs","article_published_time":"2024-08-09T05:35:57+00:00","article_modified_time":"2025-01-30T10:55:39+00:00","author":"Rnm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Rnm","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#article","isPartOf":{"@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/"},"author":{"name":"Rnm","@id":"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/c803658b38f2490f6a75863d05644438"},"headline":"Mankind Pharma to Buy Bharat Serums as Advent International Exits","datePublished":"2024-08-09T05:35:57+00:00","dateModified":"2025-01-30T10:55:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/"},"wordCount":1551,"publisher":{"@id":"https:\/\/www.rnm.in\/blog\/#organization"},"articleSection":["Corporate Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/","url":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/","name":"Mankind Pharma to Buy Bharat Serums as Advent International Exits","isPartOf":{"@id":"https:\/\/www.rnm.in\/blog\/#website"},"datePublished":"2024-08-09T05:35:57+00:00","dateModified":"2025-01-30T10:55:39+00:00","description":"Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of $1.63 billion.","breadcrumb":{"@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rnm.in\/blog\/mankind-pharma-to-buy-bharat-serums-as-advent-international-exits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rnm.in\/blog\/"},{"@type":"ListItem","position":2,"name":"Mankind Pharma to Buy Bharat Serums as Advent International Exits"}]},{"@type":"WebSite","@id":"https:\/\/www.rnm.in\/blog\/#website","url":"https:\/\/www.rnm.in\/blog\/","name":"RNM India Blogs","description":"","publisher":{"@id":"https:\/\/www.rnm.in\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rnm.in\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rnm.in\/blog\/#organization","name":"RNM India Blogs","url":"https:\/\/www.rnm.in\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rnm.in\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rnm.in\/blog\/wp-content\/uploads\/2024\/08\/cropped-logo.png","contentUrl":"https:\/\/www.rnm.in\/blog\/wp-content\/uploads\/2024\/08\/cropped-logo.png","width":137,"height":72,"caption":"RNM India Blogs"},"image":{"@id":"https:\/\/www.rnm.in\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/c803658b38f2490f6a75863d05644438","name":"Rnm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rnm.in\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/719d6dbaa9fb6a42b8e1c14dec8f0172?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/719d6dbaa9fb6a42b8e1c14dec8f0172?s=96&d=mm&r=g","caption":"Rnm"},"url":"https:\/\/www.rnm.in\/blog\/author\/rnm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/posts\/1926"}],"collection":[{"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/comments?post=1926"}],"version-history":[{"count":7,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/posts\/1926\/revisions"}],"predecessor-version":[{"id":2130,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/posts\/1926\/revisions\/2130"}],"wp:attachment":[{"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/media?parent=1926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/categories?post=1926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rnm.in\/blog\/wp-json\/wp\/v2\/tags?post=1926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}